Paul Xia

Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world.

Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.

Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide.

Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

The Chinese Institute of Certified Public Accountants operates as an accounting organization. The private company is based in Beijing, China.

Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China.

Capsilon Corp. provides cloud-based document sharing, imaging, and collaboration solutions for businesses. It products include Capsilon IQ and Instant Underwriter. The company was founded by Sanjeev Malaney in 2004 and is headquartered in San Francisco, CA.

Stone Ridge Asset Management LLC (Stone Ridge) is a registered investment advisor headquartered in New York City. The firm was founded in 2012 and is a subsidiary of Stone Ridge Holdings Group LP. Stone Ridge serves as the investment adviser to various investment companies, pooled investment vehicles, Longtail Insurance Holdings Ltd., and investors in separately managed accounts.

Nantong Sanjian Holdings Co., Ltd. engages in the operation of investment activities. Its business segment is categorized as financial investment, real estate development, and research and development of new construction industry.The company was founded on December 29, 2015 and is headquartered in Nantong, China.

Khazanah Nasional Bhd. (Private Equity) (Khazanah Nasiona) is a Private Equity firm, a subsidiary of Khazanah Nasional Bhd. founded in 1994. The firm is headquartered in Malaysia.

Innovation Meiland (Hefei) Co., Ltd. engages in the research, development, complex manufacturing and sales of biochemical pesticide preparation products with broad spectrum and low toxicity. The company was founded by Zhang Cai Xu on March 13, 2009 and is headquartered in Hefei, China.

Liaoning Clean Energy Group Co., Ltd. was founded in 2019 and develops, constructs and operates clean energy projects. The company is based in Shenyang, China and ultimately controlled by the Province of Liaoning (Liaoning).

Beijing Tsingsoft Technology Co., Ltd. provides software services. The private company is based in Beijing, China.

Shanghai Ennovabio Pharmaceuticals Co. Ltd. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China.

Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China.

Kontour (Xi'an) Medical Technology Co., Ltd. engages in the research and development, production, and sales service of three types of implanted medical devices. Its products include neurosurgery products, cardiothoracic surgery products, neurospine products, and oral implant system. Its products are used in neurosurgery, skull repair, and cardiothoracic surgery. The company was founded by Li Ren Hu, Li Gong Hu and Di Yuan Huang on March 14, 2005 and is headquartered in Xi'an, China.

Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China.

Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017.

Ningbo Taikang Pharmaceutical Technology Co. Ltd. is a private company that develops pharmaceutical technology. The company is based in Ningbo, China.